Siga provides update on progress in clinical trials to assess use of tpoxx ® (tecovirimat) for treatment of monkeypox

New york, oct. 12, 2022 (globe newswire) -- siga technologies, inc. (siga) (nasdaq: siga), a commercial-stage pharmaceutical company focused on the health security market, today provided an update on the status of multiple clinical trials now underway to assess the safety and efficacy of tpoxx to treat monkeypox.
SIGA Ratings Summary
SIGA Quant Ranking